Rebolj M - Search Results

1

COVID-19 disruption to cervical cancer screening in England.

Castanon A, Rebolj M, Pesola F, Pearmain P, Stubbs R. Castanon A, et al. Among authors: rebolj m. J Med Screen. 2022 Sep;29(3):203-208. doi: 10.1177/09691413221090892. Epub 2022 Apr 4. J Med Screen. 2022. PMID: 35369792 Free PMC article.

2

Has cytology become obsolete as a primary test in screening for cervical cancer?

Rebolj M, Lynge E. Rebolj M, et al. J Med Screen. 2010;17(1):1-2. doi: 10.1258/jms.2009.009098. J Med Screen. 2010. PMID: 20356936 No abstract available.

3

Outcomes in cervical screening using various cytology technologies: what's age got to do with it?

Barken SS, Rebolj M, Lynge E, Junge J, Rygaard C. Barken SS, et al. Among authors: rebolj m. Eur J Cancer Prev. 2013 Jul;22(4):367-73. doi: 10.1097/CEJ.0b013e328359cbe0. Eur J Cancer Prev. 2013. PMID: 22976387

4

Impact of technology on cytology outcome in cervical cancer screening of young and older women.

Rask J, Lynge E, Franzmann M, Hansen B, Hjortebjerg A, Rygaard C, Schledermann D, Wåhlin A, Rebolj M. Rask J, et al. Among authors: rebolj m. Int J Cancer. 2014 May 1;134(9):2168-79. doi: 10.1002/ijc.28532. Epub 2013 Oct 24. Int J Cancer. 2014. PMID: 24122730 Free article.

5

Condom use in prevention of Human Papillomavirus infections and cervical neoplasia: systematic review of longitudinal studies.

Lam JU, Rebolj M, Dugué PA, Bonde J, von Euler-Chelpin M, Lynge E. Lam JU, et al. Among authors: rebolj m. J Med Screen. 2014 Mar;21(1):38-50. doi: 10.1177/0969141314522454. Epub 2014 Jan 31. J Med Screen. 2014. PMID: 24488594 Review.

6

Cervical cancer screening at crossroads.

Lynge E, Rygaard C, Baillet MV, Dugué PA, Sander BB, Bonde J, Rebolj M. Lynge E, et al. Among authors: rebolj m. APMIS. 2014 Aug;122(8):667-73. doi: 10.1111/apm.12279. APMIS. 2014. PMID: 25046198 Review.

7

Cervical cancer screening in the Faroe Islands.

Hammer T, Lynge E, Djurhuus GW, Joensen JE, Køtlum JE, Hansen SÓ, Sander BB, Mogensen O, Rebolj M. Hammer T, et al. Among authors: rebolj m. Acta Oncol. 2015 Feb;54(2):210-6. doi: 10.3109/0284186X.2014.986287. Epub 2014 Dec 15. Acta Oncol. 2015. PMID: 25495570

8

Hysterectomy and its impact on the calculated incidence of cervical cancer and screening coverage in Denmark.

Lam JU, Lynge E, Njor SH, Rebolj M. Lam JU, et al. Among authors: rebolj m. Acta Oncol. 2015;54(8):1136-43. doi: 10.3109/0284186X.2015.1016625. Epub 2015 Mar 24. Acta Oncol. 2015. PMID: 25800858

9

Is a delay in the introduction of human papillomavirus-based cervical screening affordable?

Castañon A, Rebolj M, Sasieni P. Castañon A, et al. Among authors: rebolj m. J Med Screen. 2019 Mar;26(1):44-49. doi: 10.1177/0969141318800355. Epub 2018 Oct 3. J Med Screen. 2019. PMID: 30280637 Free PMC article.

10

Primary cervical screening with high risk human papillomavirus testing: observational study.

Rebolj M, Rimmer J, Denton K, Tidy J, Mathews C, Ellis K, Smith J, Evans C, Giles T, Frew V, Tyler X, Sargent A, Parker J, Holbrook M, Hunt K, Tidbury P, Levine T, Smith D, Patnick J, Stubbs R, Moss S, Kitchener H. Rebolj M, et al. BMJ. 2019 Feb 6;364:l240. doi: 10.1136/bmj.l240. BMJ. 2019. PMID: 30728133 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

106 results

Search Page